Accessibility Menu

Henry Schein(FRA) HS2

Market Cap€8.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1999)+2,024%
5 Year+31%
1 Year+7%
1 Month+4%
€76.50
-0.65%
-0.50Today
Henry Schein last closing stock price
MetricPriceDate
Last closeEUR 75.882025-12-10
Henry Schein stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.12%EUR 72.882025-12-03
1 month+3.95%EUR 73.002025-11-10
3 month+17.03%EUR 64.842025-03-14
Year to date+13.12%EUR 67.082024-12-30
1 year+6.87%EUR 71.002024-12-10
3 year-1.89%EUR 77.342022-12-09
5 year+31.17%EUR 57.852020-12-11
Since inception+2,024.14%EUR 3.631999-08-10

Henry Schein Financials at a Glance

Market Cap

€8.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€11.66K

Net Income (TTM)

€365.22

EPS (TTM)

€2.94

P/E Ratio

26.17

Dividend

€0.00

Beta (Volatility)

0.04 (Low)

Price

€76.50

Volume

0

Open

€76.50

Previous Close

€76.50

Daily Range

€76.50 - €76.50

52-Week Range

€52.42 - €78.50

Estimated Earnings Date

N/A

HS2 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Henry Schein

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

25,000

CEO

Frederick M. Lowery

Website

www.henryschein.com

HS2 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

12.13%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

3.82%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€8.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

111.45M

Volume

0

Avg. Volume

6.136

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Henry Schein Performance Analysis

Henry Schein annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 12,033,595,68414.7%
20232023-12-31EUR 11,413,210,545-5.2%
20242024-12-31EUR 11,715,917,8132.7%
20252025-12-31EUR 11,681,957,806-0.3%
Henry Schein annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 3.72-0.2%
20232023-12-31EUR 2.92-21.4%
20242024-12-31EUR 2.82-3.4%
20252025-12-31EUR 2.902.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€2.97K

+1.0%

Gross Profit

€886.72

+1.1%

Gross Margin

29.81%

+1.0%

Market Cap

€8.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.33

N/A

Employees

25,000

N/A

Net Income

€87.73

+1.1%

EBITDA

€245.12

+1.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€3.47K

+16.4%

Total Debt

€3.34K

+1.2%

Accounts Receivable

€1.54K

+1.1%

Inventory

€1.80K

+1.1%

Long Term Debt

€2.25K

+1.1%

Short Term Debt

€1.08K

+1.3%

Return on Assets

3.59%

+0.9%

Return on Invested Capital

9.19%

+0.9%

Free Cash Flow

€181.69

+2.4%

Operating Cash Flow

€207.62

+2.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About HS2

What is the current price of Henry Schein?

Henry Schein is trading at €76.50 per share.

What is the 52-week range for Henry Schein?

Over the past 52 weeks, Henry Schein has traded between €52.42 and €78.50.

How much debt does Henry Schein have?

As of the most recent reporting period, Henry Schein reported total debt of €3.34B.

How much cash does Henry Schein have on hand?

Henry Schein reported €137.32M in cash and cash equivalents in its most recent financial results.

What is Henry Schein’s dividend yield?

Henry Schein does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services